Measuring and Estimating the Effect Sizes of Copy Number Variants on General Intelligence in Community-Based Samples
Copy number variants (CNVs) classified as pathogenic are identified in 10% to 15% of patients referred for neurodevelopmental disorders. However, their effect sizes on cognitive traits measured as a continuum remain mostly unknown because most of them are too rare to be studied individually using as...
Saved in:
| Published in: | JAMA psychiatry (Chicago, Ill.) Vol. 75; no. 5; p. 447 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
01.05.2018
|
| ISSN: | 2168-6238, 2168-6238 |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Copy number variants (CNVs) classified as pathogenic are identified in 10% to 15% of patients referred for neurodevelopmental disorders. However, their effect sizes on cognitive traits measured as a continuum remain mostly unknown because most of them are too rare to be studied individually using association studies.
To measure and estimate the effect sizes of recurrent and nonrecurrent CNVs on IQ.
This study identified all CNVs that were 50 kilobases (kb) or larger in 2 general population cohorts (the IMAGEN project and the Saguenay Youth Study) with measures of IQ. Linear regressions, including functional annotations of genes included in CNVs, were used to identify features to explain their association with IQ. Validation was performed using intraclass correlation that compared IQ estimated by the model with empirical data.
Performance IQ (PIQ), verbal IQ (VIQ), and frequency of de novo CNV events.
The study included 2090 European adolescents from the IMAGEN study and 1983 children and parents from the Saguenay Youth Study. Of these, genotyping was performed on 1804 individuals from IMAGEN and 977 adolescents, 445 mothers, and 448 fathers (484 families) from the Saguenay Youth Study. We observed 4928 autosomal CNVs larger than 50 kb across both cohorts. For rare deletions, size, number of genes, and exons affect IQ, and each deleted gene is associated with a mean (SE) decrease in PIQ of 0.67 (0.19) points (P = 6 × 10-4); this is not so for rare duplications and frequent CNVs. Among 10 functional annotations, haploinsufficiency scores best explain the association of any deletions with PIQ with a mean (SE) decrease of 2.74 (0.68) points per unit of the probability of being loss-of-function intolerant (P = 8 × 10-5). Results are consistent across cohorts and unaffected by sensitivity analyses removing pathogenic CNVs. There is a 0.75 concordance (95% CI, 0.39-0.91) between the effect size on IQ estimated by our model and IQ loss calculated in previous studies of 15 recurrent CNVs. There is a close association between effect size on IQ and the frequency at which deletions occur de novo (odds ratio, 0.86; 95% CI, 0.84-0.87; P = 2.7 × 10-88). There is a 0.76 concordance (95% CI, 0.41-0.91) between de novo frequency estimated by the model and calculated using data from the DECIPHER database.
Models trained on nonpathogenic deletions in the general population reliably estimate the effect size of pathogenic deletions and suggest omnigenic associations of haploinsufficiency with IQ. This represents a new framework to study variants too rare to perform individual association studies and can help estimate the cognitive effect of undocumented deletions in the neurodevelopmental clinic. |
|---|---|
| AbstractList | Copy number variants (CNVs) classified as pathogenic are identified in 10% to 15% of patients referred for neurodevelopmental disorders. However, their effect sizes on cognitive traits measured as a continuum remain mostly unknown because most of them are too rare to be studied individually using association studies.Importance;Copy number variants (CNVs) classified as pathogenic are identified in 10% to 15% of patients referred for neurodevelopmental disorders. However, their effect sizes on cognitive traits measured as a continuum remain mostly unknown because most of them are too rare to be studied individually using association studies.To measure and estimate the effect sizes of recurrent and nonrecurrent CNVs on IQ.ObjectiveTo measure and estimate the effect sizes of recurrent and nonrecurrent CNVs on IQ.This study identified all CNVs that were 50 kilobases (kb) or larger in 2 general population cohorts (the IMAGEN project and the Saguenay Youth Study) with measures of IQ. Linear regressions, including functional annotations of genes included in CNVs, were used to identify features to explain their association with IQ. Validation was performed using intraclass correlation that compared IQ estimated by the model with empirical data.Design, Setting, and ParticipantsThis study identified all CNVs that were 50 kilobases (kb) or larger in 2 general population cohorts (the IMAGEN project and the Saguenay Youth Study) with measures of IQ. Linear regressions, including functional annotations of genes included in CNVs, were used to identify features to explain their association with IQ. Validation was performed using intraclass correlation that compared IQ estimated by the model with empirical data.Performance IQ (PIQ), verbal IQ (VIQ), and frequency of de novo CNV events.Main Outcomes and MeasuresPerformance IQ (PIQ), verbal IQ (VIQ), and frequency of de novo CNV events.The study included 2090 European adolescents from the IMAGEN study and 1983 children and parents from the Saguenay Youth Study. Of these, genotyping was performed on 1804 individuals from IMAGEN and 977 adolescents, 445 mothers, and 448 fathers (484 families) from the Saguenay Youth Study. We observed 4928 autosomal CNVs larger than 50 kb across both cohorts. For rare deletions, size, number of genes, and exons affect IQ, and each deleted gene is associated with a mean (SE) decrease in PIQ of 0.67 (0.19) points (P = 6 × 10-4); this is not so for rare duplications and frequent CNVs. Among 10 functional annotations, haploinsufficiency scores best explain the association of any deletions with PIQ with a mean (SE) decrease of 2.74 (0.68) points per unit of the probability of being loss-of-function intolerant (P = 8 × 10-5). Results are consistent across cohorts and unaffected by sensitivity analyses removing pathogenic CNVs. There is a 0.75 concordance (95% CI, 0.39-0.91) between the effect size on IQ estimated by our model and IQ loss calculated in previous studies of 15 recurrent CNVs. There is a close association between effect size on IQ and the frequency at which deletions occur de novo (odds ratio, 0.86; 95% CI, 0.84-0.87; P = 2.7 × 10-88). There is a 0.76 concordance (95% CI, 0.41-0.91) between de novo frequency estimated by the model and calculated using data from the DECIPHER database.ResultsThe study included 2090 European adolescents from the IMAGEN study and 1983 children and parents from the Saguenay Youth Study. Of these, genotyping was performed on 1804 individuals from IMAGEN and 977 adolescents, 445 mothers, and 448 fathers (484 families) from the Saguenay Youth Study. We observed 4928 autosomal CNVs larger than 50 kb across both cohorts. For rare deletions, size, number of genes, and exons affect IQ, and each deleted gene is associated with a mean (SE) decrease in PIQ of 0.67 (0.19) points (P = 6 × 10-4); this is not so for rare duplications and frequent CNVs. Among 10 functional annotations, haploinsufficiency scores best explain the association of any deletions with PIQ with a mean (SE) decrease of 2.74 (0.68) points per unit of the probability of being loss-of-function intolerant (P = 8 × 10-5). Results are consistent across cohorts and unaffected by sensitivity analyses removing pathogenic CNVs. There is a 0.75 concordance (95% CI, 0.39-0.91) between the effect size on IQ estimated by our model and IQ loss calculated in previous studies of 15 recurrent CNVs. There is a close association between effect size on IQ and the frequency at which deletions occur de novo (odds ratio, 0.86; 95% CI, 0.84-0.87; P = 2.7 × 10-88). There is a 0.76 concordance (95% CI, 0.41-0.91) between de novo frequency estimated by the model and calculated using data from the DECIPHER database.Models trained on nonpathogenic deletions in the general population reliably estimate the effect size of pathogenic deletions and suggest omnigenic associations of haploinsufficiency with IQ. This represents a new framework to study variants too rare to perform individual association studies and can help estimate the cognitive effect of undocumented deletions in the neurodevelopmental clinic.Conclusions and RelevanceModels trained on nonpathogenic deletions in the general population reliably estimate the effect size of pathogenic deletions and suggest omnigenic associations of haploinsufficiency with IQ. This represents a new framework to study variants too rare to perform individual association studies and can help estimate the cognitive effect of undocumented deletions in the neurodevelopmental clinic. Copy number variants (CNVs) classified as pathogenic are identified in 10% to 15% of patients referred for neurodevelopmental disorders. However, their effect sizes on cognitive traits measured as a continuum remain mostly unknown because most of them are too rare to be studied individually using association studies. To measure and estimate the effect sizes of recurrent and nonrecurrent CNVs on IQ. This study identified all CNVs that were 50 kilobases (kb) or larger in 2 general population cohorts (the IMAGEN project and the Saguenay Youth Study) with measures of IQ. Linear regressions, including functional annotations of genes included in CNVs, were used to identify features to explain their association with IQ. Validation was performed using intraclass correlation that compared IQ estimated by the model with empirical data. Performance IQ (PIQ), verbal IQ (VIQ), and frequency of de novo CNV events. The study included 2090 European adolescents from the IMAGEN study and 1983 children and parents from the Saguenay Youth Study. Of these, genotyping was performed on 1804 individuals from IMAGEN and 977 adolescents, 445 mothers, and 448 fathers (484 families) from the Saguenay Youth Study. We observed 4928 autosomal CNVs larger than 50 kb across both cohorts. For rare deletions, size, number of genes, and exons affect IQ, and each deleted gene is associated with a mean (SE) decrease in PIQ of 0.67 (0.19) points (P = 6 × 10-4); this is not so for rare duplications and frequent CNVs. Among 10 functional annotations, haploinsufficiency scores best explain the association of any deletions with PIQ with a mean (SE) decrease of 2.74 (0.68) points per unit of the probability of being loss-of-function intolerant (P = 8 × 10-5). Results are consistent across cohorts and unaffected by sensitivity analyses removing pathogenic CNVs. There is a 0.75 concordance (95% CI, 0.39-0.91) between the effect size on IQ estimated by our model and IQ loss calculated in previous studies of 15 recurrent CNVs. There is a close association between effect size on IQ and the frequency at which deletions occur de novo (odds ratio, 0.86; 95% CI, 0.84-0.87; P = 2.7 × 10-88). There is a 0.76 concordance (95% CI, 0.41-0.91) between de novo frequency estimated by the model and calculated using data from the DECIPHER database. Models trained on nonpathogenic deletions in the general population reliably estimate the effect size of pathogenic deletions and suggest omnigenic associations of haploinsufficiency with IQ. This represents a new framework to study variants too rare to perform individual association studies and can help estimate the cognitive effect of undocumented deletions in the neurodevelopmental clinic. |
| Author | Tihy, Frédérique Labbe, Aurélie Poline, Jean-Baptiste Huguet, Guillaume Schumann, Gunter Jiang, Lai Mathieu, Alexandre Pausova, Zdenka Schramm, Catherine Lemyre, Emmanuelle Greenwood, Celia Mathonnet, Géraldine Nizard, Sonia Conrod, Patricia Toro, Roberto Paus, Tomas Bourgeron, Thomas Loth, Eva Douard, Elise Jacquemont, Sébastien |
| Author_xml | – sequence: 1 givenname: Guillaume surname: Huguet fullname: Huguet, Guillaume organization: Center Hospitalier Universitaire Sainte-Justine Research Center, Montreal, Quebec, Canada – sequence: 2 givenname: Catherine surname: Schramm fullname: Schramm, Catherine organization: Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada – sequence: 3 givenname: Elise surname: Douard fullname: Douard, Elise organization: Center Hospitalier Universitaire Sainte-Justine Research Center, Montreal, Quebec, Canada – sequence: 4 givenname: Lai surname: Jiang fullname: Jiang, Lai organization: Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada – sequence: 5 givenname: Aurélie surname: Labbe fullname: Labbe, Aurélie organization: Département de Sciences de la Décision, HEC Montreal, Montreal, Quebec, Canada – sequence: 6 givenname: Frédérique surname: Tihy fullname: Tihy, Frédérique organization: Center Hospitalier Universitaire Sainte-Justine Research Center, Montreal, Quebec, Canada – sequence: 7 givenname: Géraldine surname: Mathonnet fullname: Mathonnet, Géraldine organization: Center Hospitalier Universitaire Sainte-Justine Research Center, Montreal, Quebec, Canada – sequence: 8 givenname: Sonia surname: Nizard fullname: Nizard, Sonia organization: Center Hospitalier Universitaire Sainte-Justine Research Center, Montreal, Quebec, Canada – sequence: 9 givenname: Emmanuelle surname: Lemyre fullname: Lemyre, Emmanuelle organization: Center Hospitalier Universitaire Sainte-Justine Research Center, Montreal, Quebec, Canada – sequence: 10 givenname: Alexandre surname: Mathieu fullname: Mathieu, Alexandre organization: Centre National de la Recherche Scientifique Genes, Synapses and Cognition Laboratory, Institut Pasteur, Paris, France – sequence: 11 givenname: Jean-Baptiste surname: Poline fullname: Poline, Jean-Baptiste organization: Department of Psychology, Berkeley University, Berkeley, California – sequence: 12 givenname: Eva surname: Loth fullname: Loth, Eva organization: Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, England – sequence: 13 givenname: Roberto surname: Toro fullname: Toro, Roberto organization: Centre National de la Recherche Scientifique Genes, Synapses and Cognition Laboratory, Institut Pasteur, Paris, France – sequence: 14 givenname: Gunter surname: Schumann fullname: Schumann, Gunter organization: Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, England – sequence: 15 givenname: Patricia surname: Conrod fullname: Conrod, Patricia organization: Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, England – sequence: 16 givenname: Zdenka surname: Pausova fullname: Pausova, Zdenka organization: The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada – sequence: 17 givenname: Celia surname: Greenwood fullname: Greenwood, Celia organization: Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada – sequence: 18 givenname: Tomas surname: Paus fullname: Paus, Tomas organization: Child Mind Institute, New York, New York – sequence: 19 givenname: Thomas surname: Bourgeron fullname: Bourgeron, Thomas organization: Human Genetics and Cognitive Functions, University Paris Diderot, Sorbonne Paris Cité, Paris, France – sequence: 20 givenname: Sébastien surname: Jacquemont fullname: Jacquemont, Sébastien organization: Center Hospitalier Universitaire Sainte-Justine Research Center, Montreal, Quebec, Canada |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29562078$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkMFOwzAMhiM0xMbYK6AcuXQkabOmR5jGmDTgMOBaea27ZWrTkqSH8vQEARK-2L_1ybK-SzIyrUFCKGdzzhi_PUEDnRuKowZvh7lgXM0Zi7MzMhF8oaKFiNXo3zwmM-dOLJRiLInVBRmLTC4ES9WE-CcE11ttDhRMSVfO6wb8d_RHpKuqwsLTnf5ER9uKLttuoM99s0dL38FqMD7sDV2jQQs13RiPda0PaAqk2gS-aXqj_RDdg8OS7qDpanRX5LyC2uHst0_J28PqdfkYbV_Wm-XdNgKZch9VyFDGQsmiLGRSxmkSI694ghIykUgZYgKYcMgy4GkhUGUCmAgcLvYiQzElNz93O9t-9Oh83mhXhA_BYNu7PKhLmUyUigN6_Yv2-wbLvLPBgx3yP1PiC7zxcd0 |
| CitedBy_id | crossref_primary_10_1016_j_ajhg_2020_04_004 crossref_primary_10_1016_j_rasd_2022_102055 crossref_primary_10_1002_hbm_25354 crossref_primary_10_1176_appi_ajp_21111175 crossref_primary_10_1134_S1022795422100040 crossref_primary_10_1176_appi_ajp_2021_21040432 crossref_primary_10_1038_s41380_024_02706_2 crossref_primary_10_1007_s11920_019_1125_x crossref_primary_10_1038_s41431_020_0672_2 crossref_primary_10_1176_appi_ajp_20240445 crossref_primary_10_1016_j_biopsych_2022_08_024 crossref_primary_10_1002_ajmg_a_61522 crossref_primary_10_1016_j_biopsych_2025_06_010 crossref_primary_10_1017_S0033291720005279 crossref_primary_10_1016_j_bbi_2020_04_051 crossref_primary_10_1038_s41380_020_00985_z crossref_primary_10_1016_S2215_0366_19_30123_3 crossref_primary_10_1016_j_biopsych_2021_05_028 crossref_primary_10_1097_YCO_0000000000000456 crossref_primary_10_1038_s41467_024_46784_w crossref_primary_10_3389_fpsyt_2024_1369767 crossref_primary_10_1016_j_neubiorev_2023_105201 crossref_primary_10_1038_s41551_025_01454_0 crossref_primary_10_1016_j_pneurobio_2020_101898 crossref_primary_10_1093_brain_awab096 crossref_primary_10_1002_brb3_2221 crossref_primary_10_1016_j_biopsych_2023_01_028 crossref_primary_10_1134_S1022795422100027 crossref_primary_10_3390_genes12050632 crossref_primary_10_1016_j_gde_2021_03_002 crossref_primary_10_1038_s41386_021_00988_6 crossref_primary_10_1038_s41467_023_44120_2 crossref_primary_10_1038_s41398_025_03324_4 crossref_primary_10_1176_appi_ajp_20220304 crossref_primary_10_1007_s11920_021_01225_z crossref_primary_10_1136_jmedgenet_2018_105879 crossref_primary_10_1038_s41398_021_01460_1 crossref_primary_10_1016_j_biopsych_2020_11_025 crossref_primary_10_1038_s41398_021_01213_0 crossref_primary_10_1176_appi_ajp_2020_19080834 crossref_primary_10_1016_j_jpsychires_2018_06_001 crossref_primary_10_1038_s41380_020_0820_7 crossref_primary_10_1038_s41380_020_0822_5 crossref_primary_10_1038_s41380_022_01906_y crossref_primary_10_1002_jcla_23822 crossref_primary_10_1016_j_gde_2020_12_012 crossref_primary_10_1002_gepi_22344 crossref_primary_10_1038_s41398_022_02263_8 crossref_primary_10_1176_appi_ajp_20220790 crossref_primary_10_3389_fpsyt_2021_645746 crossref_primary_10_1038_s41398_022_02188_2 crossref_primary_10_1038_s41586_022_04549_9 crossref_primary_10_1192_bjp_2018_301 crossref_primary_10_1212_NXG_0000000000000378 crossref_primary_10_1016_j_euroneuro_2021_02_020 crossref_primary_10_1002_wps_21034 crossref_primary_10_1038_s41380_023_01978_4 crossref_primary_10_1038_s41398_021_01490_9 crossref_primary_10_1038_s41591_019_0581_5 crossref_primary_10_1038_s41398_020_01050_7 crossref_primary_10_3390_genes13010106 crossref_primary_10_1038_s41398_023_02421_6 |
| ContentType | Journal Article |
| CorporateAuthor | IMAGEN Consortium |
| CorporateAuthor_xml | – name: IMAGEN Consortium |
| DBID | NPM 7X8 |
| DOI | 10.1001/jamapsychiatry.2018.0039 |
| DatabaseName | PubMed MEDLINE - Academic |
| DatabaseTitle | PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2168-6238 |
| ExternalDocumentID | 29562078 |
| Genre | Journal Article |
| GroupedDBID | -DZ 0R~ 4.4 5RS 9M8 AAGZG ABIVO ABJNI ABPMR ACDNT ACGFS ACHQT ACNCT ADBBV AENEX AFCHL AHMBA ALMA_UNASSIGNED_HOLDINGS AMJDE ANMPU BRYMA C45 EBD EBS EJD EMOBN EX3 HF~ KOO M5~ NPM OB2 OBH OCB OFXIZ OGEVE OHH OMH OVD PQQKQ RAJ SV3 TEORI WH7 WOW XJT YIN 7X8 ADHGD ADXHL |
| ID | FETCH-LOGICAL-a571t-fe0e53285cdc54d3743e1f14e5a9245543e4ae41a99a17c2e892a02374e6b29e2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 71 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000431347000010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2168-6238 |
| IngestDate | Thu Oct 02 06:50:33 EDT 2025 Wed Feb 19 02:43:25 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-a571t-fe0e53285cdc54d3743e1f14e5a9245543e4ae41a99a17c2e892a02374e6b29e2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://jamanetwork.com/journals/jamapsychiatry/articlepdf/2675296/jamapsychiatry_huguet_2018_oi_180002.pdf |
| PMID | 29562078 |
| PQID | 2017054883 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2017054883 pubmed_primary_29562078 |
| PublicationCentury | 2000 |
| PublicationDate | 2018-05-01 |
| PublicationDateYYYYMMDD | 2018-05-01 |
| PublicationDate_xml | – month: 05 year: 2018 text: 2018-05-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | JAMA psychiatry (Chicago, Ill.) |
| PublicationTitleAlternate | JAMA Psychiatry |
| PublicationYear | 2018 |
| SSID | ssj0000800438 |
| Score | 2.5281088 |
| Snippet | Copy number variants (CNVs) classified as pathogenic are identified in 10% to 15% of patients referred for neurodevelopmental disorders. However, their effect... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 447 |
| Title | Measuring and Estimating the Effect Sizes of Copy Number Variants on General Intelligence in Community-Based Samples |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/29562078 https://www.proquest.com/docview/2017054883 |
| Volume | 75 |
| WOSCitedRecordID | wos000431347000010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LSwMxEA5qRbz4ftQXEbwGmuz7JFpa9NBSqEpvJZvMQi-71V2F-uud2U2tJxG8LOxhw5JMMt9MvvmGsRtC0ZBqK_ys41FJDog4lUYoLU0YmcCGpmk2EQ2H8WSSjFzCrXS0yuWZWB_UtjCUI8cgnYRf0Ny82_mroK5RdLvqWmiss5aHUIasOprE3zkWQkN-3cxayTAW6OljR-ZZCg-tKMXE8iJapfcL1qx9Tn_3v3-7x3Yc2uR3jXnsszXID9jWwN2nH7JqUKcI0X1xnVvew_1OCBZfERfyRtmYj2efUPIi491ivuDDuoUIf8EYmyg0vMi5k67mjz_kPfks5674pFqIe_SVlo81SRGXR-y533vqPgjXh0HoIJKVyKADgafiwFgT-NZD0AEykz4EGqM3xCMe-Bp8qZNEy8goiBOlEQtEPoSpSkAds428yOGU8TRTiYTYGktSgyEVziYqsl7SwTHSULXZ9XI-p2jndHmhcyjey-lqRtvspFmU6bwR5JgqDPIUYp2zP3x9zrZppRvO4gVrZbjL4ZJtmo9qVr5d1QaEz-Fo8AU609B- |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Measuring+and+Estimating+the+Effect+Sizes+of+Copy+Number+Variants+on+General+Intelligence+in+Community-Based+Samples&rft.jtitle=JAMA+psychiatry+%28Chicago%2C+Ill.%29&rft.au=Huguet%2C+Guillaume&rft.au=Schramm%2C+Catherine&rft.au=Douard%2C+Elise&rft.au=Jiang%2C+Lai&rft.date=2018-05-01&rft.eissn=2168-6238&rft_id=info:doi/10.1001%2Fjamapsychiatry.2018.0039&rft_id=info%3Apmid%2F29562078&rft_id=info%3Apmid%2F29562078&rft.externalDocID=29562078 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2168-6238&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2168-6238&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2168-6238&client=summon |